David Berman's Insider Trades & SAST Disclosures
David Berman's most recent trade in Immunocore Holdings plc - ADR was a trade of 129,518 Employee Share Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 17, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern David Berman.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Immunocore Holdings plc - ADR | David Berman | HEAD OF R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2025 | 129,518 | 129,518 | - | - | Employee Share Option (Right to Buy) | |
| Immunocore Holdings plc - ADR | David Berman | HEAD OF R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2025 | 47,297 | 47,297 | - | - | Restricted Share Units | |
| Immunocore Holdings plc - ADR | David Berman | HEAD OF R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.46 per share. | 28 Feb 2024 | 36,509 | 36,509 | - | 17.5 | 637,447 | Ordinary Shares |
| Immunocore Holdings plc - ADR | David Berman | HEAD OF R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2024 | 36,509 | 271,790 | - | - | Employee Share Option (Right to Buy) | |
| Immunocore Holdings plc - ADR | David Berman | HEAD OF R&D | Sale of securities on an exchange or to another person at price $ 67.61 per share. | 28 Feb 2024 | 16,900 | 19,609 | - | 67.6 | 1,142,609 | Ordinary Shares |
| Immunocore Holdings plc - ADR | David Berman | HEAD OF R&D | Sale of securities on an exchange or to another person at price $ 69.73 per share. | 28 Feb 2024 | 10,937 | 1,200 | - | 69.7 | 762,637 | Ordinary Shares |
| Immunocore Holdings plc - ADR | David Berman | HEAD OF R&D | Sale of securities on an exchange or to another person at price $ 68.84 per share. | 28 Feb 2024 | 7,472 | 12,137 | - | 68.8 | 514,372 | Ordinary Shares |
| Immunocore Holdings plc - ADR | David Berman | HEAD OF R&D | Sale of securities on an exchange or to another person at price $ 70.45 per share. | 28 Feb 2024 | 1,200 | 0 | - | 70.5 | 84,540 | Ordinary Shares |
| Immunocore Holdings plc - ADR | David Berman | HEAD OF R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.46 per share. | 26 Feb 2024 | 54,938 | 54,938 | - | 17.5 | 959,217 | Ordinary Shares |
| Immunocore Holdings plc - ADR | David Berman | HEAD OF R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2024 | 54,938 | 308,299 | - | - | Employee Share Option (Right to Buy) | |
| Immunocore Holdings plc - ADR | David Berman | HEAD OF R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.46 per share. | 26 Feb 2024 | 28,553 | 28,553 | - | 17.5 | 498,535 | Ordinary Shares |
| Immunocore Holdings plc - ADR | Berman David | HEAD OF R&D | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2024 | 28,553 | 363,237 | - | - | Employee Share Option (Right to Buy) | |
| Immunocore Holdings plc - ADR | Berman David | HEAD OF R&D | Sale of securities on an exchange or to another person at price $ 70.60 per share. | 26 Feb 2024 | 26,516 | 2,037 | - | 70.6 | 1,872,030 | Ordinary Shares |
| Immunocore Holdings plc - ADR | David Berman | HEAD OF R&D | Sale of securities on an exchange or to another person at price $ 71.32 per share. | 26 Feb 2024 | 25,944 | 3,394 | - | 71.3 | 1,850,326 | Ordinary Shares |
| Immunocore Holdings plc - ADR | Berman David | HEAD OF R&D | Sale of securities on an exchange or to another person at price $ 70.42 per share. | 26 Feb 2024 | 21,152 | 29,338 | - | 70.4 | 1,489,524 | Ordinary Shares |
| Immunocore Holdings plc - ADR | Berman David | HEAD OF R&D | Sale of securities on an exchange or to another person at price $ 69.45 per share. | 26 Feb 2024 | 4,448 | 50,490 | - | 69.5 | 308,914 | Ordinary Shares |
| Immunocore Holdings plc - ADR | David Berman | HEAD OF R&D | Sale of securities on an exchange or to another person at price $ 71.97 per share. | 26 Feb 2024 | 3,394 | 0 | - | 72.0 | 244,266 | Ordinary Shares |
| Immunocore Holdings plc - ADR | David Berman | HEAD OF R&D | Sale of securities on an exchange or to another person at price $ 71.31 per share. | 26 Feb 2024 | 2,037 | 0 | - | 71.3 | 145,258 | Ordinary Shares |
| Immunocore Holdings plc - ADR | Berman David | HEAD OF R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 111,244 | 111,244 | - | - | Employee Share Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges